Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0001564590-20-038441 General Corporate
Debt relative to revenue 100th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.debt_to_revenue
228.57% · OPTIONAL · VALID
Capex intensity 91th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.capex_revenue_ratio
8.30% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
28.76% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-38.70% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 100th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
75.87% · OPTIONAL · VALID
Gross margin 0th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.gross_margin
13.32% · CORE · VALID
Operating margin 9th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.operating_margin
0.77% · CORE · VALID
R&D intensity 100th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.51% · OPTIONAL · VALID
SBC intensity 36th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.39% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 168.59%
Current 228.57%
Delta 59.98% Capex Intensity Increased
Previous 7.18%
Current 8.30%
Delta 1.12% Cash Generation Increased
Previous 3.38%
Current 28.76%
Delta 25.38% Growth Decreased
Previous -15.88%
Current -38.70%
Delta -22.82% Inventory Pressure Increased
Previous 66.06%
Current 75.87%
Delta 9.81% Margin Decreased
Previous 21.55%
Current 13.32%
Delta -8.23% Profitability Decreased
Previous 3.38%
Current 0.77%
Delta -2.61% R And D Intensity Increased
Previous 1.97%
Current 2.51%
Delta 0.54% Sbc Intensity Increased
Previous 0.28%
Current 0.39%
Delta 0.10% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.